Results 311 to 320 of about 3,567,395 (381)

Short‐ and Long‐Term Outcomes of Subtotal Gastrectomy for Remnant Gastric Cancer: A Multicenter Study

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
This multicenter study compared subtotal versus completion gastrectomy for remnant gastric cancer. Subtotal gastrectomy was associated with shorter operative time and significantly less postoperative weight loss, with no difference in long‐term survival, suggesting it as a feasible surgical option without compromising oncologic outcomes.
Kensuke Kudou   +9 more
wiley   +1 more source

Significance of Self‐Expandable Metallic Stent for Postoperative Intra‐Abdominal Infection After Pancreatoduodenectomy in Patients With a Hard Pancreas

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
ABSTRACT Background Self‐expandable metal stents (SEMS) are often used for preoperative biliary drainage in pancreatoduodenectomy (PD); however, their impact on postoperative intra‐abdominal infection (POAI) remains unclear. This study aimed to evaluate the clinical significance of SEMS in relation to POAI.
Kosuke Mori   +9 more
wiley   +1 more source

Impact of Two‐Team Surgery on Short‐ and Long‐Term Outcomes of Transanal Total Mesorectal Excision for Rectal Cancer

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
This study investigated the impact of two‐team surgery on short‐ and long‐term outcomes of transanal total mesorectal excision for rectal cancer. Two‐team surgery has some advantages over one‐team surgery, such as shorter operation time, decreased estimated blood loss, increased number of lymph nodes dissected, and decreased positive distal margin ...
Nobuaki Hoshino   +13 more
wiley   +1 more source

Current Status of Multidisciplinary Treatment Strategies for Hepatocellular Carcinoma in the Era of Advanced Systemic Therapies

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
ABSTRACT The therapeutic landscape of hepatocellular carcinoma (HCC) has been transformed by recent advancements in systemic therapies, particularly with the introduction of immune checkpoint inhibitors, expanding treatment options beyond conventional locoregional approaches.
Keiichi Akahoshi   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy